» Articles » PMID: 36701591

The National Clinical Care Commission Report to Congress: Summary and Next Steps

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2023 Jan 26
PMID 36701591
Authors
Affiliations
Soon will be listed here.
Abstract

The U.S. is experiencing an epidemic of type 2 diabetes. Socioeconomically disadvantaged and certain racial and ethnic groups experience a disproportionate burden from diabetes and are subject to disparities in treatment and outcomes. The National Clinical Care Commission (NCCC) was charged with making recommendations to leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC determined that diabetes cannot be addressed simply as a medical problem but must also be addressed as a societal problem requiring social, clinical, and public health policy solutions. As a result, the NCCC's recommendations address policies and programs of both non-health-related and health-related federal agencies. The NCCC report, submitted to the U.S. Congress on 6 January 2022, makes 39 specific recommendations, including three foundational recommendations that non-health-related and health-related federal agencies coordinate their activities to better address diabetes, that all federal agencies and departments ensure that health equity is a guiding principle for their policies and programs that impact diabetes, and that all Americans have access to comprehensive and affordable health care. Specific recommendations are also made to improve general population-wide policies and programs that impact diabetes risk and control, to increase awareness and prevention efforts among those at high risk for type 2 diabetes, and to remove barriers to access to effective treatments for diabetes and its complications. Finally, the NCCC recommends that an Office of National Diabetes Policy be established to coordinate the activities of health-related and non-health-related federal agencies to address diabetes prevention and treatment. The NCCC urges Congress and the Secretary of Health and Human Services to implement these recommendations to protect the health and well-being of the more than 130 million Americans at risk for and living with diabetes.

Citing Articles

Breaking Barriers: CDC and American Diabetes Association Unite to Combat Diabetes.

Holliday C, Gabbay R Prev Chronic Dis. 2025; 22:E08.

PMID: 40014539 PMC: 11870020. DOI: 10.5888/pcd22.240273.


Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysis.

Falk E, Staab E, Deckard A, Uranga S, Thomas N, Wan W Diabetes Care. 2024; 47(9):1704-1712.

PMID: 39190927 PMC: 11362130. DOI: 10.2337/dc24-0375.


Optimal Management of Insulin in Patients Undergoing 18F-Fluorodeoxyglucose Positron Emission Tomography Scans.

Seth S, Gallagher E Endocr Pract. 2023; 29(9):705-709.

PMID: 37369292 PMC: 10529812. DOI: 10.1016/j.eprac.2023.06.006.


The National Clinical Care Commission Report to Congress: Recommendations to Better Leverage Federal Policies and Programs to Prevent and Control Diabetes.

Herman W, Schillinger D, Bolen S, Boltri J, Bullock A, Chong W Diabetes Care. 2023; 46(2):255-261.

PMID: 36701592 PMC: 9887614. DOI: 10.2337/dc22-1587.

References
1.
Lock K . Health impact assessment. BMJ. 2000; 320(7246):1395-8. PMC: 1118057. DOI: 10.1136/bmj.320.7246.1395. View

2.
Greenlee M, Bolen S, Chong W, Dokun A, Gonzalvo J, Hawkins M . The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Improve Diabetes Treatment and Reduce Complications. Diabetes Care. 2023; 46(2):e51-e59. PMC: 9887628. DOI: 10.2337/dc22-0621. View

3.
Herman W, Bullock A, Boltri J, Conlin P, Greenlee M, Lopata A . The National Clinical Care Commission Report to Congress: Background, Methods, and Foundational Recommendations. Diabetes Care. 2023; 46(2):e14-e23. PMC: 9887619. DOI: 10.2337/dc22-0611. View

4.
Schillinger D, Bullock A, Powell C, Fukagawa N, Greenlee M, Towne J . The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs for Population-Level Diabetes Prevention and Control: Recommendations From the National Clinical Care Commission. Diabetes Care. 2023; 46(2):e24-e38. PMC: 9887620. DOI: 10.2337/dc22-0619. View

5.
Boltri J, Tracer H, Strogatz D, Idzik S, Schumacher P, Fukagawa N . The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes. Diabetes Care. 2023; 46(2):e39-e50. PMC: 9887613. DOI: 10.2337/dc22-0620. View